StockpollyBeta
Get App
Popularity #2,350
MGTX · NASDAQ · Biotechnology

MeiraGTx (MGTX)

Develops locally delivered AAV gene therapies and manufactures its own viral vectors.

$11.51
vs last close−0.84 (−6.77%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue52101121240750321
Cost of revenue04301212130037
Gross profit5−2−30−11011075−3314
384244463941424646483870
Research & development283434352624333333313258
108101113209121418912
Selling & marketing0−4−3003000000
General & administrative1012131113179121418912
Other expenses00000−30000−30
Operating income−33−44−47−46−40−31−42−45−4626−41244
−126426−31−826−4−11−5−81
Interest income111111100001
Interest expense333333333334
Other non-operating income8−67−30−1−44−5−9183−79
Income before tax−4420−20−49−39−39−40−39−5115−46163
Income tax expense000000000002
Net income from continuing operations−4420−20−49−39−39−40−39−5115−46161
Net income−4420−20−49−39−39−40−39−5115−46161
EPS, basic−$0.74$0.32−$0.32−$0.76−$0.55−$0.50−$0.51−$0.48−$0.62$0.19−$0.57$1.76
EPS, diluted−$0.74$0.32−$0.32−$0.76−$0.55−$0.50−$0.51−$0.48−$0.62$0.19−$0.57$1.71
Weighted average shares, basic606464647270798181818191
Weighted average shares, diluted606464647270798181818194
EBITDA−3728−14−42−33−33−34−33−4421−40323
Depreciation & amortization343333333330
EBIT−4124−17−45−36−36−37−36−4718−43323